HYBRITECH INCORPORATED

Hybritech Incorporated develops and markets monoclonal antibodies. It is a biotechnology company that uses these antibodies to make diagnostic and medical monitoring tests to identify a variety of infectious, viral and cancer-related diseases such as colon and prostate cancer, infertility, allergies, and issues that arise during pregnancy. Hybritech Incorporated was established in 1978 and is based in San Diego, California. Hybritech, Inc. operates as a subsidiary of Danaher Corp.
HYBRITECH INCORPORATED
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Mountain View, California, United States
Country:
United States
Total Employee:
51+
Status:
Active
Contact:
650-810-1990
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Apache AJAX Libraries API COVID-19 Apache 2.4 Ubuntu Facebook Domain Insights
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nationโs leading comprehensive, integrated health systems.
More informations about "Hybritech Incorporated"
Entrepreneur Opens Clinical Cancer Facility - The Scientist โฆ
Dec 9, 1990 Bioscientist Royston turns his attention to creating a center in San Diego's crowded research community Ivor Royston, who at the age of 33 founded Hybritech Inc., the first โฆSee details»
Hybritech - Crunchbase Company Profile & Funding
Hybritech is a San Diego-based medical research company. Hybritech is a San Diego-based medical research company develops and markets monoclonal antibodies which are used in โฆSee details»
Hybritech Company Profile 2024: Valuation, Investors ... - PitchBook
Hybritech was founded in 1977. Where is Hybritech headquartered? Hybritech is headquartered in San Diego, CA. What industry is Hybritech in? Hybritechโs primary industry is Drug Discovery. โฆSee details»
Hybritech, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Hybritech, Inc. with its drug pipeline, therapeutic area, technology platform, 71 literature, Drug:HYB-241, Monoclonal antibody T101-Y-90 conjugate.See details»
Hybritech Incorporated - Crunchbase
Hybritech Incorporated develops and markets monoclonal antibodies.See details»
San Diegoโs Hybritech still influences local biotech, 40 โฆ
May 9, 2018 When Hybritech was sold for $450 million in 1986, its executives and investors became rich. This spawned San Diegoโs biotech ecosystem, a self-perpetuating cycle of growth, acquisition, and more ...See details»
Company History Timeline - Beckman
Established Health Care Products Organization to combine and direct all Beckman health care activities. ... over three years. Beckman introduced its World Wide Web site. Beckman โฆSee details»
Hybritech, Inc. - University of California, San Diego
Hybritech, Inc. History. Cancer researcher Ivor Royston and lab technician Howard Birndorf of the University of California, San Diego, found Hybritech, Inc. in La Jolla, an upscale beach town just north of San Diego. Seed money for โฆSee details»
Organizational Culture for Hybritech Incorporated B
Need Help with Hybritech Incorporated B Organizational Culture? Order & download for $12See details»
Hybritech Incorporated - LinkedIn
Hybritech Incorporated Biotechnology Follow Report this company About us Industry Biotechnology Company size 201-500 employees Similar pages HYBRITECH. CON โฆSee details»
Hybritech Inc โ Filings and Transcripts โ BamSEC
SEC filings and transcripts for Hybritech Inc, including financials, news, proxies, indentures, prospectuses, and credit agreementsSee details»
Hybritech - Wikipedia
This page was last edited on 3 October 2008, at 06:45 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...See details»
Ivor Royston - Hybritech archives - Science History Institute
This collection is a private scrapbook kept by Dr. Royston documenting the highpoints of his Hybritech venture. Dates. Creation: 1978-2003 Creation: Majority of material found within 1983 โฆSee details»
Hybritech Incorporated (A) - SSRN
Hybritech Incorporated Annual Report: Monoclonal antibody technology is only ten years old. Yet, it has already been acknowledged as an achievement worthy of a Nobel Prize. In 1984 Cesar โฆSee details»
Hybritech Incorporated - Tech Stack, Apps, Patents & Trademarks
Hybritech Incorporated has 1 registered patent in the ' Testing ' category, according to IPqwery. Additionally, Hybritech Incorporated has registered 8 trademarks with the most popular class โฆSee details»
Beckman Facilities - Hybritech, Incorporated, undated
Beckman Facilities - Hybritech, Incorporated, undated File โ Box: 57, Folder: 23 Citation Staff Only Science History Institute Archives Beckman Historical Collection (2012-002) Series X. โฆSee details»
Hybritech Incorporated (a) by Robert F. Bruner, Casey Opitz - SSRN
Oct 21, 2008 HYBRITECH INCORPORATED (A) In September 1985 Ted Greene, chairman and CEO of Hybritech, met with the company's investment banker at Goldman, Sachs to discuss โฆSee details»
[8 Steps] Hybritech Incorporated (A) Case Study Finance Solution
Nov 3, 2024 Hybritech Incorporated is a young biotechnology company specializing in the development and commercialization of diagnostic products using monoclonal antibody โฆSee details»
(PDF) Hybritech Incorporated (A) - ResearchGate
Oct 21, 2008 The "Hybritech, Incorporated (B)" case (UVA-F-0793) is the follow-up case dealing with the payment structure of the acquisition. View full-text. Article. Enigma Engineering, Inc. โฆSee details»